CXCL5 and myeloid sarcoma: Our findings on low sera of CXCL-5 in sera of HFD mice is in contrast to prior study showing higher levels of CXCL-5 in mice with EAE and cerebrospinal fluid of MS patients during relapse compared with remission phase of disease (49).